Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA’s Wildfire-Driven Insurance Crisis Spreads to Lower-Risk Homes Insurers have stopped covering homes in some California neighborhoods at lower risk of wildfire damage, forcing thousands of homeowners...
WA Enacts Ban on Microchipping Workers Washington Gov. Bob Ferguson (D) signed a bill ( HB 2303 ) prohibiting companies from requiring their workers to get microchip implants. The new law allows workers...
NJ Gov Wants Big Employers to Help Cover Cost of Medicaid New Jersey Gov. Mikie Sherrill (D) unveiled a state budget plan that proposes generating $145 million in funding for Medicaid by requiring large...
When Michigan Gov. Gretchen Whitmer (D) spoke about the need for affordable healthcare and housing last month , she joined a chorus of governors of both major parties who have made affordability a focus...
MI to Weigh Ban on Stock Buybacks for Companies Receiving Tax Breaks Michigan Sen. Mallory McMorrow (D) introduced a bill ( SB 783 ) that would prohibit publicly traded companies receiving economic incentives...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
On Oct. 3 Colorado’s Prescription Drug Affordability Review Board set an upper payment limit, or UPL, for Enbrel, a prescription drug used to treat rheumatoid arthritis and other autoimmune diseases. The cap—limiting what insurers and patients pay for the medication to no more than about $31,000 per year, nearly half the $53,049 average amount insurance plans paid for the drug in 2023—is the first such limit to be imposed in the nation. (COLORADO SUN)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.